MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.transproceed.2023.09.010

Медицинская библиотека · Transplantation proceedings · 2023

Benefits of Routine Screening for Renal Cell Carcinoma of Native Kidney in Renal Transplant Recipients.

Singh-Singh Arshdeep, Vigara Luis Alberto, Aguilera Aurora, Carrasco Daniel, Alonso Marta, Amaro Jose Manuel, Cazorla Juan Manuel, Villanego Florentino, Mazuecos Auxiliadora, García Teresa

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Renal-cell carcinoma (RCC) is the most common solid organ cancer in kidney transplantation recipients (KTRs).

BACKGROUND

Analyze the incidence, prognosis, and evolution of primitive kidney RCC in KTRs at our institution.

MATERIAL AND

METHODS

Observational descriptive retrospective study in which all KTRs from January 2000 to December 2022 were included. We performed an annual abdominal ultrasound in all KTRs. Demographic and clinical data were collected. The surgical approach, location, size, histologic type, and tumor grade were analyzed. We assessed the coexistence of risk factors. We reported the appearance of tumors in other locations, changes in immunosuppressants (IS) after the diagnosis, and survival and recurrence rates observed during follow-up.

RESULTS

Eighteen RCCs of native kidneys were diagnosed with an incidence in our population of 1.08%. The majority were men (77.8%), with a mean age of 59.9 years. The pathologic analysis revealed 11 clear cell carcinomas, 6 papillary carcinomas, and 1 chromophobe cell carcinoma. The median tumor size was 2.7 cm. TNM stage was T1aN0M0 in 15 cases. Laparoscopy was performed to remove the tumor in most cases. All our patients underwent changes in IS therapy, with conversion to mammalian target of rapamycin inhibitors when possible and reduction of IS in all of them. After a mean follow-up of 78.6 months, survival was 100% without tumor recurrence. Seven of the patients were diagnosed with a new tumor in another location.

CONCLUSION

In our experience, annual abdominal ultrasound in KTRs may be an option for the early detection of RCC in native kidneys.

Для цитирования: Singh-Singh Arshdeep, Vigara Luis Alberto, Aguilera Aurora, Carrasco Daniel, Alonso Marta, Amaro Jose Manuel, Cazorla Juan Manuel, Villanego Florentino, Mazuecos Auxiliadora, García Teresa. Benefits of Routine Screening for Renal Cell Carcinoma of Native Kidney in Renal Transplant Recipients.. Transplantation proceedings. 2023. DOI: 10.1016/j.transproceed.2023.09.010.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.